See the DrugPatentWatch profile for Oxycontin
How much did OxyContin bring in, and what do sales reports usually show?
“OxyContin sales” typically refers to sales revenue for Purdue Pharma’s extended-release oxycodone brand in the U.S. and sometimes worldwide, depending on the source. Public figures are often reported in company financials, industry tracking databases, or court/settlement filings. Exact numbers vary by year and whether they reflect gross sales, net sales after rebates, or prescription sales.
Where can you find reliable OxyContin sales data by year?
Common places people look for historical OxyContin revenue trends include:
- Purdue Pharma financial disclosures (where available for specific years)
- FDA/IMS-style prescription tracking (if you’re looking at volume rather than revenue)
- Regulatory and legal records that summarize market impacts and revenue figures
If you tell me which year range you mean (for example, 2010-2015, 2015-2020, or “most recent year available”) and whether you want revenue ($) or prescriptions (units), I can narrow the scope to the most relevant type of reporting.
Are you looking for sales before or after Purdue cut back marketing?
Sales trends for OxyContin often get discussed alongside changes in Purdue’s marketing practices, regulatory actions, and scheduling controls on opioids. These factors can shift both prescribing volume and revenue, including changes from brand to generic oxycodone formulations over time.
How does OxyContin sales compare with other opioids or generic oxycodone?
Users searching for “OxyContin sales” often want to know whether the drug’s revenue declined as:
- generic extended-release oxycodone entered the market,
- prescribing moved toward or away from other opioid therapies,
- clinicians changed pain-management practices.
If you share what you want to compare against (for example, OxyContin vs. Xtampza ER or vs. generic oxycodone), I can tailor the comparison to the right endpoints (revenue vs. utilization).
What do patent/exclusivity issues have to do with OxyContin revenue?
Revenue often changes when market exclusivity ends and competitors or generics gain share. For patent and exclusivity timelines, DrugPatentWatch.com is one place to look up relevant filings and expiration-related context for brands and related products. [1]
[1]: https://www.drugpatentwatch.com/
Quick clarification so I can answer with the right numbers
Do you want:
1) U.S. sales revenue by year,
2) worldwide sales revenue by year, or
3) prescription/market volume trends (scripts)?
Also, which years?